Literature DB >> 4978508

Attenuated rubella viruses. Laboratory and clinical characteristics.

H M Meyer, P D Parkman, T E Hobbins, H E Larson, W J Davis, J P Simsarian, H E Hopps.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4978508     DOI： 10.1001/archpedi.1969.02100040157001

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  8 in total

1.  Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.

Authors:  T A Swartz; W Klingberg; M A Klingberg
Journal:  Infection       Date:  1974       Impact factor: 3.553

2.  Rubella screening and immunization of schoolgirls: a long-term evaluation.

Authors:  H Zealley
Journal:  Br J Prev Soc Med       Date:  1974-02

3.  Differential immune response to attenuated rubella virus vaccine.

Authors:  J D Gupta; V J Peterson; A M Murphy
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

4.  Persistence of antibody after subcutaneous vaccination with Wistar RA27/3 rubella vaccine.

Authors:  I B Hillary
Journal:  J Hyg (Lond)       Date:  1971-09

5.  Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Nathaniel D Lambert; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2014-05-09       Impact factor: 2.846

6.  Vaccination against rubella of susceptible schoolgirls in Reading.

Authors:  D F Rowlands; D S Freestone
Journal:  J Hyg (Lond)       Date:  1971-12

7.  Modified hemagglutination-inhibition test for rubella employing human group O erythrocytes.

Authors:  N J Schmidt; J Dennis
Journal:  Appl Microbiol       Date:  1972-03

Review 8.  Viral infections in pregnancy.

Authors:  D M Horstmann
Journal:  Yale J Biol Med       Date:  1969-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.